RBRoland L. Bell

Roland L. Bell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roland L. Bell has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Bruno Zwingenberger

    University Center of Orthopedic, Trauma and Plastic Surgery, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany

    1 shared publication
  • Corina Vater

    University Center of Orthopaedic, Trauma and Plastic Surgery, University Hospital Carl Gustav Carus and Faculty of Medicine at TUD Dresden University of Technology, 01307, Dresden, Germany; Center for Translational Bone, Joint and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine at TUD Dresden University of Technology, 01307, Dresden, Germany

    1 shared publication
  • Dilbar Aibibu

    Institute of Textile Machinery and High Performance Material Technology, Technische Universität Dresden Dresden Germany

    1 shared publication
  • Elisabeth Mehnert

    University Center of Orthopedic, Trauma and Plastic Surgery, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

    1 shared publication
  • Julia Bolte

    University Center of Orthopedic, Trauma and Plastic Surgery, University Hospital Carl Gustav Carus at TU Dresden, 01307 Dresden, Germany

    1 shared publication
  • Ronny Brünler

    Institute of Textile Machinery and High Performance Material Technology (ITM), Technische Universität Dresden, Hohe Str. 6, 01069 Dresden, Germany

    1 shared publication

Latest Publications

  • Open Access

    Treatment of Critical-Size Femoral Bone Defects with Chitosan Scaffolds Produced by a Novel Process from Textile Engineering

    by Bruno Zwingenberger, Corina Vater, Roland L. Bell, Julia Bolte, Elisabeth Mehnert, Ronny Brünler, Dilbar Aibibu, Stefan Zwingenberger

    The purpose of this study was to investigate, in vitro and in vivo, the suitability of chitosan (CHS) scaffolds produced by the net-shape-nonwoven (NSN) technology, for use as bone graft substitutes in a critical-size femoral bone defect in rats. For in vitro investigations, scaffolds made of CHS, mineralized collagen (MCM), or human cancellous bone allograft (CBA) were seeded with human telomerase-immortalized mesenchymal stromal cells (hTERT-MSC), incubated for 14 days, and thereafter evaluated for proliferation and osteogenic differentiation. In vivo, CHS, MCM and CBA scaffolds were implanted into 5 mm critical-size femoral bone defects in rats. After 12 weeks, the volume of newly formed bone was determined by microcomputed tomography (µCT), while the degree of defect healing, as well as vascularization and the number of osteoblasts and osteoclasts, was evaluated histologically. In vitro, CHS scaffolds showed significantly higher osteogenic properties, whereas treatment with CHS, in vivo, led to a lower grade of bone-healing compared to CBA and MCM. While chitosan offers a completely new field of scaffold production by fibers, these scaffolds will have to be improved in the future, regarding mechanical stability and osteoconductivity.